How to start tirzepatide: you begin at 2.5 mg once weekly, submitted through TelosRX's asynchronous intake process and reviewed by a licensed provider before your first dose is dispensed. Compounded tirzepatide is not FDA-approved and requires a provider-issued prescription.
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two hunger-signaling pathways instead of one. That's why the titration protocol matters. Start too high, and nausea derails your first month. Follow the schedule, and most people tolerate it well.
Here's exactly how to do it, step by step.
Step 1: Complete Your Asynchronous Medical Evaluation
Your first step isn't a syringe. It's a detailed health intake form — the same one your licensed provider reviews to determine whether tirzepatide is appropriate for you.
At TelosRX, this process is fully asynchronous: your licensed provider reviews your medical history, current medications, and health goals on their schedule, typically responding within one business day. No live appointment required.
What your intake evaluation covers:
- Current BMI and weight history
- Relevant diagnoses: type 2 diabetes, prediabetes, obesity, metabolic syndrome
- Current medications (especially insulin or sulfonylureas, which can interact with tirzepatide)
- Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- Kidney and liver function
- GI history — gastroparesis is a contraindication
- History of pancreatitis
Approval is not guaranteed. Your provider may request additional information or decline to prescribe based on your individual history. This provider gate is how safe prescribing works.
Step 2: Receive and Store Your Medication
Once your provider issues a prescription, compounded tirzepatide ships refrigerated. Proper storage protects potency.
| Storage Condition | Requirement |
|---|---|
| Unopened vial | Refrigerate 36–46°F (2–8°C). Do not freeze. |
| Vial in active use | Up to 21 days at room temperature below 86°F (30°C) |
| Light exposure | Protect from light; keep in original packaging until use |
| Appearance check | Do not use if cloudy, discolored, or contains particles |
You'll receive syringes, alcohol swabs, and a sharps disposal container. Stage everything before Day 1 so your first injection isn't a scavenger hunt.
Step 3: Prepare and Administer Your First Injection
Your first dose is 2.5 mg, injected subcutaneously (just under the skin). Follow your provider-issued instructions precisely — the steps below are a general orientation, not a substitute for your pharmacy's specific guidance.
- Wash your hands thoroughly with soap and water.
- Draw the prescribed volume into the syringe exactly as your pharmacy instructed.
- Choose an injection site: abdomen (at least 2 inches from the navel), outer upper thigh, or back of the upper arm. Rotate sites each week.
- Clean the site with an alcohol swab and allow it to dry for 10 seconds.
- Pinch 1–2 inches of skin. Insert the needle at a 45–90° angle, depending on your body composition.
- Inject slowly and steadily. Remove the needle and apply light pressure with a clean swab — do not rub.
- Dispose of the needle immediately in your sharps container. Never recap and reuse.
Mild stinging or a small red spot at the injection site is normal. A firm lump persisting beyond 48 hours warrants a message to your provider.
Step 4: Follow the Titration Schedule
Titration means increasing the dose gradually — every four weeks — to let your body adapt before the next step. This is not a test of willpower. It's pharmacology. Slow titration reduces side effects without meaningfully slowing your results.
| Weeks | Dose | Primary Purpose |
|---|---|---|
| 1–4 | 2.5 mg weekly | Tolerability baseline; GI adaptation |
| 5–8 | 5 mg weekly | Initial therapeutic range |
| 9–12 | 7.5 mg weekly (if indicated) | Escalation; increased appetite suppression |
| 13–16 | 10 mg weekly (if indicated) | Continued escalation |
| 17–20 | 12.5 mg weekly (if indicated) | Approaching maintenance range |
| 21+ | 15 mg weekly (if indicated) | Maximum approved dose |
Your provider determines the escalation pace. Not everyone needs — or tolerates — higher doses. Many people find their effective dose well below 15 mg. Escalation decisions require provider review and a provider-issued updated prescription.
If side effects are significant at a new dose level, your provider may hold the titration at the current level for an additional four weeks before advancing. That's standard protocol, not a setback.
Wondering how tirzepatide compares to semaglutide? Our tirzepatide vs semaglutide comparison breaks down the mechanism differences and available evidence.
Step 5: Manage Side Effects Proactively
Nausea is the most common side effect when starting tirzepatide. It's dose-dependent — tends to peak in the first week after each new dose level, then improves as your body adapts.
Practical strategies, subject to your provider's guidance:
- Eat smaller meals. Tirzepatide slows gastric emptying. Large meals feel uncomfortable on a stomach that's now emptying at half speed. Four to five smaller meals outperform two or three large ones.
- Avoid high-fat and spicy foods in the first two weeks of each new dose level. They amplify GI symptoms significantly.
- Stay hydrated. GI symptoms can accelerate fluid loss. Eight or more cups of water daily is the floor, not the ceiling.
- Eat slowly. Your GI tract is more sensitive on tirzepatide. Rushed meals worsen bloating and nausea.
- Time your injection strategically. Some people find evening injections allow them to sleep through peak nausea. Discuss timing with your provider.
- Sit upright after eating. Give your stomach 30–60 minutes before lying down.
For a detailed breakdown of what to expect and when to act, see our GLP-1 side effects management guide.
Severe persistent vomiting, inability to keep fluids down, or upper abdominal pain radiating to the back require prompt medical attention. Do not wait — contact your provider or seek emergency care immediately.
Ready to begin? TelosRX's licensed provider team reviews your intake asynchronously — no appointment needed, no waiting room.
Step 6: Support Your Progress With Lifestyle Habits
Tirzepatide suppresses appetite and alters how your body processes food. That's a metabolic advantage. What you do with it determines your long-term outcome.
Three habits that compound the medication's effect:
- Prioritize protein. Aim for 0.7–1.0 grams of protein per pound of body weight daily. Protein supports muscle retention — critical because GLP-1 medications can contribute to lean mass loss when protein intake is insufficient. Eggs, lean meat, Greek yogurt, legumes, and protein shakes all count.
- Resistance training, at least twice weekly. Even bodyweight exercises help preserve muscle. Your body weight will change regardless; what that weight is made of is what you control.
- Consistent sleep. Poor sleep raises cortisol and ghrelin — the hormone that drives hunger — which works directly against the medication's effects. Seven to nine hours of quality sleep isn't a lifestyle preference here. It's a clinical variable.
Clinical trials of tirzepatide — including the SURMOUNT-1 study published in the New England Journal of Medicine — paired medication with a reduced-calorie diet and increased physical activity. The lifestyle component was part of the protocol, not an afterthought.
Step 7: Monitor Progress and Communicate With Your Provider
Your provider needs to know how you're tolerating each dose level. At TelosRX, this happens through asynchronous platform messaging — you can update your provider without scheduling a live visit.
What to track and report monthly:
- Weight (weekly weigh-in, same day and time each week for accuracy)
- Side effect severity — nausea, constipation, fatigue — rated 1–10
- Appetite changes: frequency of genuine hunger vs. habitual eating
- Energy levels and sleep quality
- Any new medications, supplements, or health events
Periodic lab work — lipid panel, HbA1c, kidney function — may be ordered depending on your baseline health. Follow your provider's specific monitoring schedule. This is what separates clinical care from a pill-mill.
Step 8: Know When to Pause, Adjust, or Stop
Contact your provider promptly if you experience any of the following:
- Nausea or vomiting preventing you from eating or drinking for more than 24 hours
- Sustained resting heart rate increase of more than 20 bpm above your normal baseline
- Sudden vision changes (rapid HbA1c reduction in diabetic patients can temporarily affect vision)
- Signs of allergic reaction: rash, difficulty breathing, or facial/throat swelling
- Severe or persistent abdominal pain
If you're stopping intentionally — goal reached, transitioning strategies — your provider should guide the off-ramp. Research on compounding regulations and GLP-1 cessation consistently shows weight regain is common without a structured plan. Build one with your provider before stopping.
Frequently Asked Questions
How long does tirzepatide take to work?
Appetite suppression often begins within the first one to two weeks at 2.5 mg. Measurable body weight changes are typically observed by weeks four to eight. The SURMOUNT-1 trial followed participants for 72 weeks — the most substantial reductions occurred after escalation to higher dose levels. Your individual timeline is subject to provider assessment and depends on your starting point, diet, and activity level.
Can I eat normally when starting tirzepatide?
Yes, but what "normal" feels like will change. Tirzepatide slows gastric emptying, so large or high-fat meals become uncomfortable — especially in the first two weeks of each new dose level. Most people naturally shift toward smaller, protein-forward meals without feeling deprived. You don't need to follow a rigid diet plan, but the medication works better when you work with it.
What if I miss a tirzepatide dose?
If fewer than four days have passed since your scheduled injection day, take the dose as soon as you remember. If more than four days have passed, skip the missed dose and resume your normal weekly schedule. Never double up. If you're frequently missing doses, contact your provider — an injection-day adjustment may help.
How do I know when to increase my dose?
Dose escalation is determined by your provider, not self-initiated. Generally, after four weeks at a given dose with manageable side effects, your provider may advance the prescription. If side effects are significant, staying at the current dose for another four weeks is appropriate. Escalation always requires a provider-issued updated prescription.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
Compounded tirzepatide contains the same active ingredient as Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for chronic weight management). However, compounded tirzepatide is not FDA-approved. It is prepared by licensed compounding pharmacies under federal compounding regulations, prescribed off-label, and dispensed only after medical approval by a licensed provider.
Can I drink alcohol on tirzepatide?
Alcohol isn't prohibited, but two practical concerns apply. First, alcohol can worsen GI side effects — nausea on top of nausea isn't fun. Second, reduced appetite means alcohol hits harder. Moderation is the guidance, and specifics should be discussed with your provider based on your health history and medication list.
Will tirzepatide interact with my other medications?
Tirzepatide's effect on gastric emptying can delay absorption of oral medications. Oral contraceptives, insulin, and sulfonylureas require specific attention. Disclose all current medications in your intake form — your provider will assess interactions before prescribing and may adjust timing recommendations for other oral drugs.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.